Fitness Stuff (for normal people) Retatrutide, L-Theanine, The Science of Newbie Gains, & More
Mar 2, 2026
They unpack Phase 3 data on retatrutide and what the trial results mean for powerful weight-loss drugs. They explain how L-theanine affects brain chemistry and when supplementation might help. They break down the science of newbie gains, from neural adaptations to later muscle growth. They finish with a practical look at microwaves, nutrients, safety, and common myths.
AI Snips
Chapters
Transcript
Episode notes
High Dropouts Reveal Tolerability And Dosing Issues
- The retatrutide trials had much higher dropout rates than semaglutide, driven by dose-related side effects and excessive weight loss.
- 12 mg/week group had 18% dropout and 9 mg/week 12%, suggesting current trial doses may be too high for many.
Avoid Assuming Trial Doses Match Real-World Use
- Consider that effective doses reported anecdotally are far lower than trial doses; microdosing trends exist but lack evidence.
- Public reports often find 1–2 mg effective versus trial 9–12 mg, and higher doses increase nausea and dizziness.
Side Effects Are Mostly GI And Dose Dependent
- Most adverse effects of these incretin drugs are GI-related and dose dependent, not broad systemic harms.
- Aside from nausea, vomiting, constipation and fullness, trials show few other serious health event spikes and some cardio and cognitive benefits.